![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Pharmacology (C.-H.T., D.-Y.L., T.-F.H., W.-M.F.) and Orthopaedics (R.-S.Y.), College of Medicine, National Taiwan University, Taipei, Taiwan; and Office of Physical Education (T.-H.H.) and Department of Biochemistry (W.-J.C.), College of Medicine, National Cheng Kung University, Tainan, Taiwan
Received December 30, 2005; accepted March 15, 2006
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
2, 5, 
1, and 3 integrins in cultured osteoblasts, as shown by flow cytometric analysis and immunofluorescence staining. US stimulation increased prostaglandin E2 formation and the protein and mRNA levels of cyclooxygenase-2 (COX-2). At the mechanistic level, anti-integrin 51 and v3 antibodies or rhodostomin, a snake venom disintegrin, attenuated the US-induced COX-2 expression. Phosphatidylinositol 3-kinase (PI3K) inhibitors 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002) and wortmannin also inhibited the potentiating action of US. US stimulation increased the phosphorylation of focal adhesion kinase (FAK), extracellular signal-regulated kinases (ERK), p85 subunit of PI3K, and serine 473 of Akt. COX-2 promoter activity was enhanced by US stimulation in cells transfected with pCOX2-Luc. Cotransfection with dominant-negative mutant of FAK(Y397F), p85(
p85), Akt(K179A), or ERK2(K52R) inhibited the potentiating action of US on COX-2 promoter activity. Expression of mineralized nodule was lower in dominant-negative mutants of FAK, p85, and Akt-transfected clones than in vector-transfected control cells. Taken together, our results provide evidence that US stimulation increases COX-2 expression and promotes bone formation in osteoblasts via the integrin/FAK/PI3K/Akt and ERK signaling pathway.
; Wang et al., 1994) and clinical studies (Heckman et al., 1994; Cook et al., 1997).
Bone is a dynamic tissue that remodels in response to mechanical loads from the external environment (Rubin and Lanyon, 1985; Turner et al., 1994). Whereas the augmentation of fracture healing by US is well documented, the underlying mechanism of the mechanotransduction pathway involved in cellular responses to US is largely unknown. It has been demonstrated that exposure to low-intensity US pulses increases cyclooxygenase-2 (COX-2) mRNA expression and release of prostaglandin E2 (PGE2), which are required for mechanically induced bone formation (Reher et al., 2002). However, the mechanisms involved in osteoblasts to detect US stress and transduce the signal across the membrane for activating signaling pathways in bone metabolism, such as the induction of COX-2 and release of PGE2, remain poorly understood.
Integrins are cell-surface adhesion receptors that regulate cell viability in response to cues derived from the extracellular matrix (Ruoslahti, 1996; Giancotti and Ruoslahti, 1999). In the case of mesenchymal cells, encompassed by the extracellular matrix, matrix-derived mechanical stimuli can regulate their viability. In this latter scenario, integrins function as mechanoreceptors that detect mechanical stimuli originating from the extracellular matrix and convert them to chemical signaling pathways that regulate cell viability (Dimmler et al., 1998; Tian et al., 2002). Mechanical stimuli can be transmitted through the direct or indirect interaction of integrins with associated lipid or protein-signaling molecules in the focal adhesion complex (Plopper et al., 1995; Chicurel et al., 1998). Focal adhesion kinase (FAK), a potential candidate signaling molecule, has been shown to be capable of regulating integrin-mediated signaling (Crouch et al., 1996; Hadden and Henke, 2000). However, the downstream signaling pathways that mediate integrin-FAK signaling are diverse, and the factors determining which pathway is used remain obscure. Ligation and clustering of integrins activate FAK by autophosphorylation of tyrosine 397, creating a potential binding site for the SH2 domains of the p85 subunit of PI3K (Schlaepfer and Hunter, 1998; Eliceiri et al., 2002). Phosphorylation of the p85 subunit of PI3K by FAK may activate the p110 catalytic subunit of PI3K and the PI3K/Akt signaling pathway.
Intracellular signals that promote osteoblast differentiation, including those mediated by bioactive radicals such as NO, PGE, and calcium, may occur in response to cellular homeostatic disturbance induced by US (Warden et al., 2001; Reher et al., 2002). It has been reported that US exposure increased NO and PGE2 release via up-regulation of inducible nitric-oxide synthase and COX-2 in osteoblasts (Reher et al., 2002). PGE2 may enhance the maturation of osteoblast and decrease the formation of osteoclast (Take et al., 2005). However, the signaling pathway for US stimulation on COX-2 expression and bone formation is mostly unknown. Here, we found that US stimulation increased expression of integrin in cell membrane. In addition, long-term US stimulation also enhanced osteoblastic differentiation. Furthermore, integrin, FAK, ERK, PI3K, and Akt-dependent pathways may be involved in the increase of COX-2 expression and bone formation by US stimulation.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
B, phosphor-IB, ERK2, phosphor-ERK1/2, -tubulin, phosphotyrosine residues (PY20), and phosphor-Akt (Ser473) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal antibodies specific for 2, 3, 4, 5, 1, 3, and 51 integrin were purchased from Chemicon (Temecula, CA). Mouse monoclonal antibody for v3 was purchased from DAKO (Glostrup, Denmark). Rhodostomin was purified from venom of Calloselasma rhodostoma (Huang et al., 1991). The COX-2 promoter construct (pCOX2-Luc) was a gift from Dr. H. R. Herschman (University of California at Los Angeles, Los Angeles, CA). The phosphorylation site mutant of FAK(Y397F) was a gift from Dr. J. A. Girault (Institut du Fer à Moulin, Moulin, France). The p85 (p85; deletion of 35 amino acids from residues 479-513 of p85) and Akt (Akt K179A) dominant-negative mutants were gifts from Dr. R. H. Chen (Institute of Molecular Medicine, National Taiwan University, Taipei, Taiwan). The ERK2 (K52R) dominant-negative mutant was provided by Dr. M. Cobb (South-Western Medical Center, Dallas, TX). pSV--galactosidase vector and luciferase assay kit were purchased from Promega (Madison, WI). The NF-B-Luc expression plasmid was purchased from Stratagene (La Jolla, CA). All other chemicals were obtained from Sigma-Aldrich (St. Louis, MO).
Cell Cultures. A murine osteoblastic cell line MC3T3-E1 was obtained from Riken Cell Bank (Tsukuba, Japan). Cells were grown on the plastic cell culture dishes in 95% air/5% CO2 with -MEM (Invitrogen, Carlsbad, CA), which was supplemented with 20 mM HEPES and 10% heat-inactivated fetal bovine serum, 2 mM glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml), pH 7.6. The cell medium was changed twice per week.
Primary osteoblastic cells were prepared by the method described previously (Tang et al., 2003). The calvaria of fetal rats were dissected from fetal rats, divided into small pieces, and then treated with 0.1% type I collagenase solution for 10 min at 37°C. The next two 20-min sequential collagenase digestions were pooled and filtered through 70-µm nylon filters (Falcon; BD Biosciences, San Jose, CA). The cells were grown on the plastic cell culture dishes in 95% air/5% CO2 with -MEM (Invitrogen), which was supplemented with 20 mM HEPES and 10% heat-inactivated fetal bovine serum, 2 mM glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml), pH adjusted to 7.6. The characteristics of osteoblasts were confirmed by morphology and the expression of alkaline phosphatase.
Ultrasound Treatment. Cells (3 x 105 cells/well, six-well plates) were cultured for 24 h and subjected to US treatment. A UV-sterilized transducer (Exogene 2000; Smith and Nephew Inc., Memphis, TN) that generated 1.5 MHz US in a pulsed-wave mode (200-µs burst width with repetitive frequency of 1 kHz at the intensity of 30 mW/cm2) was immersed vertically into each culture well and placed to just contact the surface of the medium. The distance between the transducer and the cells was approximately 5 to 6 mm. Exposure time was 20 min/day for all cultures. Control samples were prepared in the same manner without US exposure. Cells were harvested at 1, 3, 6, 12, and 24 h after US stimulation.
Flow Cytometric Analysis. Primary osteoblasts or MC3T3-E1 cells were plated in six-well dishes. The cells were then washed with phosphate-buffered saline (PBS) and detached with trypsin at 37°C. Cells were fixed for 10 min in PBS containing 1% paraformaldehyde. After rinsing in PBS, the cells were incubated with rabbit anti-rat antibodies against 2, 3, 4, 5, 1, or 3 integrin (1:100; Chemicon) for 1 h at 4°C. Cells were then washed again and incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit secondary IgG (1:150; Leinco Tec. Inc., St. Louis, MO) for 45 min and analyzed by flow cytometry using FACSCalibur and CellQuest software (BD Biosciences).
Immunocytochemistry. Osteoblasts were grown on glass cover-slips. Cultures were rinsed once with PBS and fixed for 30 s at room temperature in acetone. Cells were then rinsed three times with PBS. After blocking with 4% bovine serum albumin for 15 min, cells were incubated with rabbit anti-rat 1 or 3 integrin (1:100) for 1 h at room temperature. Cells were then washed again and labeled with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG for 1 h. Finally, cells were washed, mounted, and examined with a Leica TCS SP2 Spectral Confocal System (Leica, Wetzlar, Germany).
Immunoprecipitation and Western Blot Analysis. The cellular lysates were prepared as described previously (Tang et al., 2005). Equal amounts of protein were incubated with specific antibody immobilized onto protein A/G-Sepharose for 12 h at 4°C with gentle rotation. Beads were washed extensively with lysis buffer, boiled, and microcentrifuged. Proteins were resolved on SDS-PAGE and transferred to Immobilon polyvinyldifluoride membranes. The blots were blocked with 4% bovine serum albumin for 1 h at room temperature and then probed with rabbit anti-rat antibodies against COX-1, COX-2, pFAK, p85, or pAkt (1:1000) for 1 h at room temperature. After three washes, the blots were subsequently incubated with a donkey anti-rabbit peroxidase-conjugated secondary antibody (1:1000) for 1 h at room temperature. The blots were visualized by enhanced chemiluminescence using Kodak X-OMAT LS film (Eastman Kodak, Rochester, NY). For normalization purposes, the same blot was also probed with mouse anti-rat -tubulin antibody (1: 1000). Quantitative data were obtained using a computing densitometer and ImageQuant software (GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Quantitative Real-Time PCR. Total RNA was extracted from osteoblasts using a TRIzol kit (MDBio Inc., Taipei, Taiwan). The reverse-transcription reaction was performed using 2 µg of total RNA that was reverse-transcribed into cDNA using oligo(dT) primer, and quantitative real-time PCR (qPCR) analysis was carried out using Taqman one-step PCR Master Mix (Applied Biosystems, Foster City, CA). Total cDNA (100 ng) was added per 25-µl reaction with sequence-specific primers and Taqman probes. Sequences for all target gene primers and probes were purchased commercially (glyceraldehyde-3-phosphate dehydrogenase was used as internal control) (Applied Biosystems). qPCR assays were carried out in triplicate on an ABI Prism 7900 sequence detection system. The cycling conditions were 10-min polymerase activation at 95°C followed by 40 cycles at 95°C for 15 s and 60°C for 60 s. The threshold was set above the nontemplate control background and within the linear phase of target gene amplification to calculate the cycle number at which the transcript was detected (denoted as CT).
PGE2 Assay. Primary osteoblast or MC3T3-E1 cells cultured in six-well plates were stimulated with US. PGE2 production was measured by a commercial ELISA kit (Cayman Chemical) according to manufacturer's instructions.
Transfection and Reporter Gene Assay. Osteoblasts were cotransfected with 1 µg of COX-2 promoter plasmid and 1 µg of -galactosidase expression vector. Osteoblasts were grown to 70% confluence in six-well plates and were transfected on the following day by Lipofectamine 2000 (LF2000), premix DNA with Opti-MEM, and LF2000 with Opti-MEM, respectively, for 5 min. The mixture was then incubated for 25 min at room temperature and added to each well. After 24-h incubation, transfection was complete, and cells were incubated with the indicated agents. The media were removed 24 h after US stimulation, and cells were washed once with cold PBS. To prepare lysates, 100 µl of reporter lysis buffer (Promega) was added to each well, and cells were scraped from dishes. The supernatant was collected after centrifugation at 13,000 rpm for 30 s. Aliquots of cell lysates (10 µl) containing equal amounts of protein (10-20 µg) were placed into wells of an opaque black 96-well microplate. An equal volume of luciferase substrate was added to all samples, and luminescence was measured in a microplate luminometer. The value of luciferase activity was normalized to transfection efficiency monitored by the cotransfected -galactosidase expression vector. In experiments using dominant-negative mutants, cells were cotransfected with reporter (0.5 µg) and -galactosidase (0.25 µg) and either the FAK(Y397F), p85, Akt, or ERK2 mutant or the empty vector (1.0 µg).
Selection of Stably Transfected Clone. Purified plasmid DNA (3 µg) was transfected into MC3T3-E1 cells with LF2000 transfection reagent. Twenty-four hours after transfection, stable transfectants were selected in gentamicin (G418; Invitrogen) at a concentration of 600 µg/ml. Thereafter, the selection medium was replaced every 3 days. After 2 weeks of selection in G418, clones of resistant cells were isolated and allowed to proliferate in medium containing G418 (100 µg/ml). Integration of transfected plasmid DNA was confirmed by reverse transcription-polymerase chain reaction and Western blot analysis.
Measurement of Mineralized Nodule Formation. Osteoblasts were cultured in -MEM containing 50 µg/ml vitamin C and 10 mM -glycerophosphate, and the medium was changed every 3 days. Ultrasound stimulation was applied every day (20 min/day), and bone nodule formation was determined on day 10 using alizarin red-S staining. In brief, the ethanol-fixed cells and matrix was stained for 1 h with 40 mM alizarin red-S, pH 4.2, and extensively rinsed with water. After photography, the bound staining was eluted with 10% (w/v) cetylpyridinium chloride, and alizarin red-S in samples was quantified by measuring absorbance at 550 nm and calculated according to a standard curve. One mol of alizarin red-S selectively binds approximately 2 mol of calcium (Yang et al., 2005).
Statistics. The values given are means ± S.E.M. The significance of difference between the experimental groups and controls was assessed by Student's t test. The difference is significant if the p value is <0.05.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
5, 1, and 3 integrins increased, starting and reaching peak between 3 and 6 h. The fluorescence intensity then gradually decreased to a resting level. We then used primary cultured osteoblasts to examine the effect of US on the integrin expression in cell membrane. A similar change of the integrin expression was obtained in primary osteoblasts, including 5, 1, and 3 integrins (Fig. 1B). Therefore, US stimulation may transiently increase the integrin expression on the cell surface of osteoblasts. We then used immunocytochemistry to visualize the localization of integrins. The 1 or 3 staining in control cells shows a punctate pattern (Fig. 1C). However, the clustering of 1 or 3 integrin was markedly enhanced 6 h after US stimulation (20-min duration), and the staining of integrin shows fibrillar pattern (Fig. 1C). In addition, US stimulation also increased the integrin expression of 2 but not 3 and 4 (Fig. 1D), suggesting that US does not up-regulate the expression of all kinds of integrin in osteoblasts. Because osteoblasts were cultured on six-well plates precoated with fibronectin, vitronectin, and collagen (10 µg/ml, 500 µl for each) for 24 h, the increase of 5, 1, and 3 integrin expression on the cell surface of osteoblasts is similar 6 h after US stimulation (Fig. 1E). These results indicate that an increase of integrin expression on the cell membrane of osteoblasts by US is not affected by precoated extracellular matrix.
|
|
51 or v3 (20 µg/ml), Arg-Gly-Asp-dependent disintegrin rhodostomin (0.28 µM), or transfection with the FAK dominant-negative mutant (Y397F) for 24 h antagonized the US-induced COX-2 expression (Fig. 3A). FAK has been shown to be capable of regulating integrin-mediated signaling (Hadden and Henke, 2000). Phosphorylation of tyrosine 397 of FAK has been used as a marker of FAK activity. As shown in Fig. 3B, FAK phosphorylation increased in a time-dependent manner in response to 20 min US stimulation, reaching the maximum between 10 and 30 min (Fig. 3B). To determine the relationship of signaling pathway among 51, v3 integrins, and FAK in response to US stimulation, cells were pretreated for 30 min with mAb against 51, v3 (20 µg/ml), or rhodostomin (0.28 µM) or transfection with FAK(Y397F) mutant for 24 h, and the results showed that US-induced FAK phosphorylation was markedly inhibited (Fig. 3C). Phosphorylation of tyrosine 397 of FAK may provide a binding site for the Src homology 2 domain of the p85 subunit of PI3K (Chan et al., 1999). Because enforced activation of 51 or v3 integrin by US stimulation potentiates FAK phosphorylation, we then examined whether US stimulation also enhances the association of FAK with PI3K. Exposure of osteoblasts to US for 20 min led to a significant increase of phosphorylation of p85 subunit of PI3K, as assessed by the measurement of phosphotyrosine from immunoprecipitated lysates using p85 (Fig. 4A). Pretreatment of osteoblasts for 30 min with mAbs against 51, v3 (20 µg/ml), rhodostomin (0.28 µM), or transfection with FAK(Y397F) mutant markedly attenuated the US-induced p85 phosphorylation (Fig. 4B). To explore whether PI3K is involved in US-induced COX-2 expression, PI3K inhibitors LY294002 and wortmannin were used. As shown in Fig. 5A, pretreatment of osteoblasts with LY294002 and wortmannin inhibited US-induced COX-2 expression in a concentration-dependent manner. Transfection of osteoblasts with p85(p85) or Akt(K179A) mutant also antagonized the potentiating effect of US. We thus directly measured the Akt phosphorylation in response to US stimulation. Figure 5B shows that US exposure in osteoblasts increased Akt phosphorylation (serine 473) in a time-dependent manner. Maximal activation was detected 15 min after US stimulation (20-min duration). Furthermore, the US-induced increase in Akt phosphorylation was markedly inhibited by the pretreatment of cells for 30 min with mAb against 51, v3 (20 µg/ml), or rhodostomin (0.28 µM) or transfection with FAK (Y397F) or p85(p85) mutant for 24 h. Taken together, these results indicate that the integrin/FAK/PI3K/Akt pathway is involved in US-induced COX-2 expression.
|
|
|
Involvement of ERK and NF-B in US-Induced COX-2 Expression. To examine whether ERK and NF-B activation are involved in the elevation of COX-2 expression caused by US stimulation, the mitogen-activated protein kinase kinase inhibitor PD98059 and the specific NF-B inhibitor PDTC were used. Pretreatment of cells for 30 min with PD98059 (10 and 30 µM) or PDTC (10 and 30 µM) inhibited the US-induced increase in COX-2 expression in a concentration-dependent manner (Fig. 6A). ERK phosphorylation increased after 20 min of US stimulation, starting at 5 min, reaching maximum between 15 and 30 min, and then gradually decreased (Fig. 6B). US-induced ERK phosphorylation was markedly inhibited if osteoblasts were pretreated for 30 min with mAb against 51, v3 (20 µg/ml), or transfection with FAK(Y397F). However, US-induced ERK phosphorylation was not affected when osteoblasts were transfected with p85(p85) or Akt(K179A) mutant (Fig. 6C). These results indicate that 51 or v3 integrins and FAK but not PI3K and Akt are upstream regulators of ERK in US-induced COX-2 expression. Exposure of cells with US results in IB phosphorylation in the cytosol and caused a marked IB degradation. In parallel to IB phosphorylation and degradation, US stimulation resulted in p65 translocation from cytosol to nucleus (Fig. 6D). Exposure of cells to US resulted in a 3-fold increase in B-luciferase activity. Pretreatment of osteoblasts for 30 min with mAb against 51 or v3 (20 µg/ml), rhodostomin (0.28 µM), or transfection with FAK(Y397F), p85(p85), Akt(K179A), or ERK(K52R) mutant for 24 h markedly antagonized US-induced increase of B-luciferase activity (Fig. 6E). These results indicate that NF-B is the downstream effector for integrin/FAK/PI3K/Akt and ERK pathways in US-induced COX-2 expression.
|
Increase of COX-2 Promoter Activity by US Stimulation. To further study the pathways involved in the action of US-induced COX-2 expression, transient transfection was performed using the mouse COX-2 promoter-luciferase construct, pCOX2-Luc, which contains the mouse COX-2 gene between positions -370 and +70 fused to the luciferase reporter gene. Exposure to US led to a 3.5-fold increase in COX-2 promoter activity in osteoblasts. The increase of COX-2 activity by US stimulation was antagonized by mAb against 51, v3 (20 µg/ml), rhodostomin (0.28 µM), LY294002 (10 µM), wortmannin (100 nM), PD98059 (30 µM), and PDTC (30 µM) (Fig. 7A). In cotransfection experiments, the increase of COX-2 promoter activity by US was inhibited by the dominant-negative mutant of FAK(Y397F), p85(p85), Akt(K179A), and ERK(K52R) (Fig. 7B). Taken together, these data suggest that the activation of the integrin/FAK/PI3K/Akt/NF-B pathway and ERK is required for the US-induced increase of COX-2 in osteoblasts.
|
US Stimulation Enhanced Bone Nodule Formation in Osteoblasts. It has been reported that US enhanced the healing of bone fracture (Duarte, 1983; Wang et al., 1994). We then investigated whether the FAK/PI3K/Akt pathway is involved in the differentiation of osteoblasts in response to long-term US stimulation. To clarify the involvement of FAK-PI3K-Akt pathway in the US-mediated bone nodule formation, FAK(Y397F), p85(p85), or Akt(K179A) mutants were transfected into MC3T3-E1 cells. After G418 selection, we isolated a single clone of MC3T3/FAKDN, MC3T3/p85DN, and MC3T3/AktDN and a vector control (MC3T3/vector). Formation of mineralized nodule is a marker for osteoblastic maturation. Alizarin red staining showed the mineralized nodules when osteoblasts were cultured in the medium containing vitamin C (50 µg/ml) and -glycerophosphate (10 mM) for 10 days (Fig. 8). MC3T3/vector cells exposed to US (20 min/day) increased bone nodule formation. However, transfection with dominant-negative mutants of FAK, p85, and Akt attenuated US-induced bone nodule formation (Fig. 8). To confirm the crucial role of COX-2 in US-induced bone formation, selective COX-2 inhibitor NS-398 was used. Treatment of osteoblasts with NS-398 (0.3 µM) for 10 days antagonized US-induced bone nodule formation (Fig. 8). These data suggest that the activation of FAK/PI3K/Akt pathway is required for US to increase COX-2 expression and bone nodule formation in osteoblasts.
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
). The noninvasive nature of US provides many advantages in practical applications. Although US is clinically used as a treatment for fracture repair, the molecular mechanisms by which US alters cell function or protein synthesis are virtually unknown. Here, we demonstrate that US exposure transiently increases the membrane expression of integrins and results in the expression of COX-2 and the formation of PGE2. Furthermore, long-term US treatment enhances the maturation of osteoblasts. The results of the present study suggest a role of integrin in the transduction of the acoustic pressure that leads to the expression of COX-2 and the enhanced maturation of osteoblasts.
Ultrasound stimuli are transferred to adherent cells through their adhesive contacts with surrounding extracellular matrix. Integrins act as a link between extracellular matrix, cytoskeletal proteins, and actin filaments (Hynes, 1992). We found previously that fibronectin fibrillogenesis is abundant underneath osteoblasts (Tang et al., 2003, 2004, 2005). 51 integrin is the classic fibronectin receptor, mediates critical interactions between osteoblasts and fibronectin, and is required for bone morphogenesis and osteoblast differentiation (Moursi et al., 1997). Flow cytometry and immunofluorescence staining revealed that short-term US treatment transiently increased the cell surface expression of 5 and 1 integrins. Other integrins such as 2 and 3 are also transiently regulated by US treatment, suggesting that many kinds of integrins are probably involved in the regulation of osteoblastic function in response to US stimuli. Integrin-signaling pathways are involved in regulating the expression of a number of genes coding for substances involved in tissue repair, including cytokines and proteases (Arner and Tortorella, 1995). In the present study, we also show that US stimulation increased COX-2 expression and PGE2 formation, as detected by Western blotting analysis, qPCR, and ELISA. Treatment with anti-51, v3 mAbs or rhodostomin (an Arg-Gly-Asp-dependent disintegrin that binds specifically to integrins IIb3, 51, and v3) antagonized the potentiating action of US stimulation on COX-2 expression, indicating that 51 and v3 integrins are very important to mediate the action of US in osteoblasts. It has been found that cyclical pressure-induced strain results in rapid tyrosine phosphorylation of FAK, paxillin, and -catenin in human articular chondrocytes (Lee et al., 2000). We demonstrate that US stimulation increased phosphorylation of tyrosine 397 of FAK. Furthermore, the FAK(Y397F) mutant antagonized the US-mediated potentiation of COX-2 expression, suggesting that FAK activation is an obligatory event in US-induced COX-2 expression in these cells.
Increase of integrin expression may be related to the reorganization of actin cytoskeleton and cytoskeletal stiffness (Yang et al., 2005). The downstream signaling to integrin may involve the activation of several protein kinases such as Src (Parsons and Parsons, 1997), PI3K (Naruse et al., 2000), or -catenin (Lee et al., 2000). Furthermore, FAK contains tyrosine residues in motifs for binding to SH2 domain. Phosphorylated tyrosine 397 of FAK has been shown to serve as a binding site for the SH2 domain of the p85 subunit of PI3K (Chen et al., 1996). Phosphorylation of the p85 subunit is required for activation of the p110 catalytic subunit of PI3K. Pretreatment of osteoblast with PI3K inhibitors LY294002 and wortmannin antagonized the increase of COX-2 expression by US stimulation. This was further confirmed by the result that the dominant-negative mutant of p85(p85) inhibited the enhancement of COX-2 promoter activity by US stimulation. The cytoplasmic serine kinase Akt was found to be activated by US stimulation in osteoblastic cells. These effects were inhibited by mAbs against 51 or v3, rhodostomin, or mutants of FAK and p85, indicating the involvement of integrin-FAK-PI3K-dependent Akt activation in US-mediated induction of COX-2. Activation of the FAK-PI3K-Akt-dependent pathway has also been reported for 1 integrin to regulate cell survival in human lung fibroblast cells (Xia et al., 2004). In addition, regulation of angiogenesis by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor is also related to v3 integrin/FAK/Akt signal cascade (Vincent et al., 2003). Take together, our results provide evidence that US up-regulates COX-2 in osteoblasts via the integrin/FAK/PI3K/Akt signaling pathway.
ERK also plays a critical role in integrin signaling (Kapur et al., 2003). We found that PD98059 (a mitogen-activated protein kinase kinase inhibitor) also inhibited US-induced COX-2 expression. Furthermore, US-induced ERK activation was antagonized by mAb against 51 or v3 integrin and FAK(Y397F) mutant but not by mutants of p85 and Akt, indicating that integrin and FAK but not PI3K and Akt might occur as the upstream molecules involved in US-induced activation of ERK. In mice and humans, the COX-2 promoter contains a binding site for many transcription factors, including NF-B in the 5' region of the COX-2 gene (Kim and Fischer, 1998). In addition, NF-B has been shown to control the induced transcription of the COX-2 gene (Schmedtje et al., 1997). In this study, we demonstrate that US-induced COX-2 expression was inhibited by the NF-B inhibitor PDTC, indicating that activation of NF-B might be involved in the induction of COX-2 protein caused by US stimulation. It has also been found that exposure of osteoblasts to US resulted in IB phosphorylation and IB degradation in the cytosol, the translocation of p65 from cytosol to nucleus. Using transient transfection with B-luciferase as an indicator of NF-B activity, we also found that US increased NF-B activity, which was inhibited by mAb against 51 or v3 integrin, rhodostomin, or DN mutants of FAK, p85, Akt, or ERK. These results indicate that US might act through the integrin, FAK, PI3K, Akt, and ERK pathway to induce NF-B activation in osteoblasts.
Intracellular signals including NO, PGE2, and calcium are involved in osteoblast differentiation and may occur in response to a cellular homeostatic disturbance induced by US (Warden et al., 2001; Reher et al., 2002). It has been reported that US exposure increased PGE2 release via up-regulation of COX-2 in osteoblast (Reher et al., 2002). We found previously that PGE2 increased bone volume in tibia metaphysis of rats (Tang et al., 2005). In this study, we demonstrate that selective COX-2 inhibitor NS-398 inhibited US-induced bone nodule formation as detected by alizarin red staining. These data suggest that COX-2 and PGE2 play a critical role in US-mediated bone nodule formation. However, the effect of US on the other prostaglandins, except PGE2, cannot be excluded. Increase of bone nodule formation by US stimulation was also antagonized by DN mutants of FAK, p85, or Akt, suggesting that the regulation of bone formation is parallel to the increase of COX-2 expression, and the FAK/PI3K/Akt pathway is involved in the potentiating action of US.
In conclusion, the signaling pathway involved in US-induced COX-2 expression in rat osteoblasts has been explored. US stimulation increases COX-2 expression through the upregulation of cell membrane integrins, activation of FAK, PI3K, Akt, ERK, and NF-B. Long-term US stimulation enhanced the differentiation of osteoblasts and bone nodule formation because of the increase of COX-2 expression.
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
ABBREVIATIONS: US, ultrasound; COX, cyclooxygenase; DN, dominant negative; ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase; NF-B, nuclear factor-B; PGE2, prostaglandin E2; PI3K, phosphatidylinositol 3-kinase; Rn, rhodostomin; PD98059, 2'-amino-3'-methoxyflavone; PDTC, pyrrolidine dithiocarbamate; LY294002, 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; qPCR, quantitative real-time polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; LF2000, Lipofectamine 2000; mAb, monoclonal antibody; MEM, minimal essential medium; Luc, luciferase; NS-398, N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methane sulfonamide.
Address correspondence to: Dr. Wen-Mei Fu, Department of Pharmacology, College of Medicine, National Taiwan University, 1, Sec. 1, Jen-Ai Road, Taipei, Taiwan. E-mail: wenmei{at}ha.mc.ntu.edu.tw
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Chan TO, Rittenhouse SE, and Tsichlis PN (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68: 965-1014.[CrossRef][Medline]
Chen HC, Appeddu PA, Isoda H, and Guan JL (1996) Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem 271: 26329-26334.
Chicurel ME, Chen CS, and Ingber DE (1998) Cellular control lies in the balance of forces. Curr Opin Cell Biol 10: 232-239.[CrossRef][Medline]
Cook SD, Ryaby JP, McCabe J, Frey JJ, Heckman JD, and Kristiansen TK (1997) Acceleration of tibia and distal radius fracture healing in patients who smoke. Clin Orthop Relat Res 337: 198-207.[CrossRef][Medline]
Crouch DH, Fincham VJ, and Frame MC (1996) Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene 12: 2689-2696.[Medline]
Dimmler S, Assmus B, Hermann C, Haendeler J, and Zeiher AM (1998) Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 83: 334-341.
Duarte LR (1983) The stimulation of bone growth by ultrasound. Arch Orthop Trauma Surg 101: 153-159.[CrossRef][Medline]
Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, and Cheresh DA (2002) Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 157: 149-159.
Giancotti FG and Ruoslahti E (1999) Integrin signaling. Science (Wash DC) 285: 1028-1032.
Hadden HL and Henke CA (2000) Induction of lung fibroblast apoptosis by soluble fibronectin peptides. Am J Respir Crit Care Med 162: 1553-1560.
Heckman JD, Ryaby JP, McCabe J, Freym JJ, and Kilcoyne RF (1994) Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg 76: 26-34.
Huang TF, Sheu JR, Teng CM, Chen SW, and Liu CS (1991) Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb/IIIa complex. J Biochem (Tokyo) 109: 328-334.
Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69: 11-25.[CrossRef][Medline]
Kapur S, Baylink DJ, and Lau KH (2003) Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32: 241-251.[Medline]
Kim Y and Fischer SM (1998) Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 273: 27686-27694.
Lee HS, Millward-Sadler SJ, Wright MO, Nuki G, and Salter DM (2000) Integrin and mechanosensitive ion channel-dependent tyrosine phosphorylation of focal adhesion proteins and beta-catenin in human articular chondrocytes after mechanical stimulation. J Bone Miner Res 15: 1501-1509.[CrossRef][Medline]
Moursi AM, Globus RK, and Damsky CH (1997) Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 110: 2187-2196.[Abstract]
Naruse K, Miyauchi A, Ifoman M, and Mikuni-Takagaki Y (2000) Anabolic response of mouse bone-marrow-derived stromal cell clone ST2 cells to low-intensity pulsed ultrasound. Biochem Biophys Res Commun 268: 216-220.[CrossRef][Medline]
Parsons JT and Parsons SJ (1997) Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 9: 187-192.[CrossRef][Medline]
Plopper GE, McNamee HP, Dike LE, Bojanowski K, and Ingber DE (1995) Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6: 1349-1365.[Abstract]
Reher P, Harris M, Whiteman M, Hai HK, and Meghji S (2002) Ultrasound stimulates nitric oxide and prostaglandin E2 production by human osteoblasts. Bone 31: 236-241.[Medline]
Rubin CT, Gross TS, McLeod KJ, and Bain SD (1995) Morphologic stages in lamellar bone formation stimulated by a potent mechanical stimulus. J Bone Miner Res 10: 488-495.[Medline]
Rubin CT and Lanyon LE (1985) Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37: 411-417.[Medline]
Ruoslahti E (1996) Integrin signaling and matrix assembly. Tumor Biol 17: 117-124.
Schlaepfer DD and Hunter T (1998) Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol 8: 151-157.[CrossRef][Medline]
Schmedtje JF, Ji YS, Liu WL, DuBois RN, and Runge MS (1997) Hypoxia induces cyclooxygenase-2 via the NF-B p65 transcription factor in human vascular endothelial cells. J Biol Chem 272: 601-608.
Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, and Takahashi N (2005) Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146: 5204-5214.
Tang CH, Yang RS, and Fu WM (2005) Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Cand c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 280: 22907-22916.
Tang CH, Yang RS, Huang TH, Liu SH, and Fu WM (2004) Enhancement of fibronectin fibrillogenesis and bone formation by basic fibroblast growth factor via protein kinase C-dependent pathway in rat osteoblasts. Mol Pharmacol 66: 440-449.
Tang CH, Yang RS, Liou HC, and Fu WM (2003) Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast. J Bone Miner Res 18: 502-511.[CrossRef][Medline]
Tian B, Lessan K, Kahm J, Kleidon J, and Henke C (2002) 1 Integrin regulates fibroblast viability during collagen matrix contraction through a phosphatidylinositol 3-kinase/Akt/protein kinase B signaling pathway. J Biol Chem 277: 24667-24675.
Turner CH, Forwood MR, and Otter MW (1994) Mechanotransduction in bone: do bone cells act as sensors of fluid flow? FASEB J 8: 875-878.[Abstract]
Vincent L, Albanese P, Bompais H, Uzan G, Vannier JP, Steg PG, Soria J, and Soria C (2003) Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Thromb Haemost 89: 530-537.[Medline]
Wang SJ, Lewallen DG, Bolander ME, Chao EY, Ilstrup DM, and Greenleaf JF (1994) Low intensity ultrasound treatment increases strength in a rat femoral fracture model. J Orthop Res 12: 40-47.[CrossRef][Medline]
Warden SJ, Favaloro JM, Bennell KL, McMeeken JM, and Zajac JD (2001) Low-intensity pulsed ultrasound stimulates a bone-forming response in UMR-106 cells. Biochem Biophys Res Commun 286: 443-450.[CrossRef][Medline]
Xia H, Nho RS, Kahm J, Kleidon J, and Henke CA (2004) Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a 1 integrin viability signaling pathway. J Biol Chem 279: 33024-33034.
Yang RS, Lin WL, Chen YZ, Tang CH, Huang TH, Lu BY, and Fu WM (2005) Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 36: 276-283.[Medline]
This article has been cited by other articles:
|
|
 |
|
  K. Ohashi, N. Ouchi, K. Sato, A. Higuchi, T.-o Ishikawa, H. R. Herschman, S. Kihara, and K. Walsh Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism Mol. Cell. Biol., July 1, 2009; 29(13): 3487 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Mahoney, M. R. Morgan, A. Harrison, M. J. Humphries, and M. D. Bass Therapeutic Ultrasound Bypasses Canonical Syndecan-4 Signaling to Activate Rac1 J. Biol. Chem., March 27, 2009; 284(13): 8898 - 8909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Tang, J.-Y. Chuang, Y.-C. Fong, M.-C. Maa, T.-D. Way, and C.-H. Hung Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-{kappa}B pathways and promotes osteoclastogenesis in human oral cancer cells Carcinogenesis, August 1, 2008; 29(8): 1483 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Khan and C. T. Laurencin Fracture Repair with Ultrasound: Clinical and Cell-Based Evaluation J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Tang, T.-W. Tan, W.-M. Fu, and R.-S. Yang Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis Carcinogenesis, January 1, 2008; 29(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Chiu, R.-S. Yang, K.-H. Hsieh, Y.-C. Fong, T.-D. Way, T.-S. Lee, H.-C. Wu, W.-M. Fu, and C.-H. Tang Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human Chondrocytes Mol. Pharmacol., September 1, 2007; 72(3): 695 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Tang, D.-Y. Lu, T.-W. Tan, W.-M. Fu, and R.-S. Yang Ultrasound Induces Hypoxia-inducible Factor-1 Activation and Inducible Nitric-oxide Synthase Expression through the Integrin/Integrin-linked Kinase/Akt/Mammalian Target of Rapamycin Pathway in Osteoblasts J. Biol. Chem., August 31, 2007; 282(35): 25406 - 25415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Tang, T.-L. Hsu, W.-W. Lin, M.-Z. Lai, R.-S. Yang, S.-L. Hsieh, and W.-M. Fu Attenuation of Bone Mass and Increase of Osteoclast Formation in Decoy Receptor 3 Transgenic Mice J. Biol. Chem., January 26, 2007; 282(4): 2346 - 2354. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|
 |
 |
 |
0.05 compared with control (n = 3).
